Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Morgan Bron, Rajeev Ayyagari, Hari Sharma, Kristina Chen, Ana Bozas & Eric Wu. (2014) Management of Patients Using Combination Therapy With Pioglitazone and a Dipeptidyl Peptidase-4 Inhibitor: An Analysis of Initial Versus Sequential Combination Therapy. Postgraduate Medicine 126:3, pages 47-55.
Read now
Read now
Shana Traina, Robert Guthrie & April Slee. (2014) The Impact of Weight Loss on Weight-related Quality of Life and Health Satisfaction: Results From a Trial Comparing Canagliflozin With Sitagliptin in Triple Therapy Among People With Type 2 Diabetes. Postgraduate Medicine 126:3, pages 7-15.
Read now
Read now
Articles from other publishers (11)
Ruping Pan, Jiadai Liu & Yong Chen. (2023) Treatment of obesity-related diabetes: significance of thermogenic adipose tissue and targetable receptors. Frontiers in Pharmacology 14.
Crossref
Crossref
Xindi Shan, Xueliang Wang, Hao Jiang, Chao Cai, Jiejie Hao & Guangli Yu. (2020) Fucoidan from Ascophyllum nodosum Suppresses Postprandial Hyperglycemia by Inhibiting Na+/Glucose Cotransporter 1 Activity. Marine Drugs 18:9, pages 485.
Crossref
Crossref
Zahra Yadollahi Farsani, Farzaneh Taghian & Ebrahim Banitalebi. (2019) Effects of different intensities of endurance training on serum fibroblast growth factor level, glucose, and insulin resistance in streptozotocin-diabetic male rats. Journal of Shahrekord University of Medical Sciences 21:3, pages 118-124.
Crossref
Crossref
Yuichiro Ito, James Van Schyndle, Takuya Nishimura, Toshifumi Sugitani & Tomomi Kimura. (2019) Characteristics of Patients with Diabetes Initiating Sodium Glucose Co-transporter-2 Inhibitors (SGLT2i): Real-World Results from Three Administrative Databases in Japan. Diabetes Therapy 10:2, pages 549-562.
Crossref
Crossref
Mohsen Sheykhhasan. (2019) Towards Standardized Stem Cell Therapy in Type 2 Diabetes Mellitus: A Systematic Review. Current Stem Cell Research & Therapy 14:1, pages 75-76.
Crossref
Crossref
Mark E. Cooper, Vlado Perkovic, Janet B. McGill, Per-Henrik Groop, Christoph Wanner, Julio Rosenstock, Uwe Hehnke, Hans-Juergen Woerle & Maximilian von Eynatten. (2015) Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes. American Journal of Kidney Diseases 66:3, pages 441-449.
Crossref
Crossref
Prasarn Manitpisitkul, Christopher R. Curtin, Kevin Shalayda, Shean-Sheng Wang, Lisa Ford & Donald Heald. (2014) Pharmacokinetic interactions between topiramate and pioglitazone and metformin. Epilepsy Research 108:9, pages 1519-1532.
Crossref
Crossref
H. ThabitK. KumareswaranA. HaidarL. LeelarathnaK. CaldwellD. ElleriJ. M. AllenM. NodaleM. E. WilinskaN. C. Jackson, A. M. Umpleby, M. L. EvansR. Hovorka. (2014) Glucose Turnover After Replacement of Usual Therapy by Insulin in Insulin-naive Type 2 Diabetes Subjects. The Journal of Clinical Endocrinology & Metabolism 99:6, pages 2225-2232.
Crossref
Crossref
Binita Shah, Jeffrey S. Berger, Nicholas S. Amoroso, Xingchen Mai, Jeffrey D. Lorin, Ann Danoff, Arthur Z. Schwartzbard, Iryna Lobach, Yu Guo, Frederick Feit, James Slater, Michael J. Attubato & Steven P. Sedlis. (2014) Periprocedural Glycemic Control in Patients With Diabetes Mellitus Undergoing Coronary Angiography With Possible Percutaneous Coronary Intervention. The American Journal of Cardiology 113:9, pages 1474-1480.
Crossref
Crossref
M.K. Sangeetha, Nitin ShriShri Mal, K. Atmaja, Veeresh Kumar Sali & Hannah R. Vasanthi. (2013) PPAR’s and Diosgenin a chemico biological insight in NIDDM. Chemico-Biological Interactions 206:2, pages 403-410.
Crossref
Crossref
D. Müller-Wieland. (2013) Neue MedikamenteNew drugs. Der Diabetologe 9:4, pages 296-301.
Crossref
Crossref